“chimerix” Archives

in
Entry Author Date Location
Bio Roundup: Gilead’s Pionyr Grab, Relay to IPO, Unicorn Sana & More 06/26/20 National
San Antonio Researchers Plan Trials for Drug Combo to Treat Ebola 06/03/16 Texas
Chimerix, TransEnterix, BDSI, Duke Energy & More NC Innovation News 05/16/16 Raleigh Durham
Precision BioSciences, Chimerix, Spreedly, & More NC Innovation News 02/29/16 Raleigh Durham
After Failed Trial, Chimerix Shuts Down Two More Phase 3 Tests 02/22/16 Raleigh Durham
Chimerix, DeSimone, Merz, & More in NC Innovation News 01/04/16 Raleigh Durham
Chimerix Stock Plunges After Anti-Infection Drug Fails Phase 3 Trial 12/28/15 Raleigh Durham
With $16M Series B, Antiva Hopes to Kill Cancer-Causing HPV 08/06/15 San Francisco
Raleigh-Durham Roundup: Chimerix, vTv, Biotech Center, & More 07/27/15 Raleigh Durham
Chimerix Preps $150M Stock Sale to Match Rising R&D 06/09/15 Raleigh Durham
Chimerix Drug Shows Promise As Virus Fighter for Transplant Patients 03/02/15 Raleigh Durham
For Life Science Industry, Social Media Takes on New Significance 02/19/15 Raleigh Durham
Raleigh-Durham Roundup: BioCryst, Scioderm, Red Hat & More 12/22/14 Raleigh Durham
How Ebola Drug Trials Today Could Shape Future Drug Development 12/09/14 Raleigh Durham
Raleigh-Durham Roundup: Appia, Chimerix, Ascletis & More 11/17/14 Raleigh Durham
Chimerix Plans $105M Stock Offering to Finance Ebola Drug Trials 10/30/14 Raleigh Durham
J&J, GSK, Tekmira, And Others Take Next Steps To Fight Ebola 10/22/14 Boston
Chimerix Antiviral to Start in Ebola Clinical Trial 10/16/14 Raleigh Durham
Raleigh-Durham Roundup: Targacept, Chimerix, Red Hat, & More 10/13/14 Raleigh Durham
As Virus Spreads to U.S., Tekmira CEO Answers Ebola Questions 10/07/14 Seattle
Texas Ebola Patient Gets Chimerix Drug, Clinical Trials Planned 10/06/14 Raleigh Durham
Biotech Unveils Drug for Viral Infections Tied to Cervical Cancer 08/22/14 San Diego
Reflections on RTP 07/24/14 Raleigh Durham
Which VCs Are Poised to Profit From the Biotech IPO Boom? 09/09/13 National
The Biotech IPO Phenomenon of 2013: Enjoy It While It Lasts 07/22/13 National
Why We Think Investing in Antibiotics Makes Sense 09/14/10 San Francisco
Page 1 of 1